Switzerland. Assessment of ACTH-Adrenal Activity and Diagnostic Value of Plasma ACTH.
In primary adrenal insufficiency plasma ACTH values are 5-10 times above the upper normal limit (80-100 pg/ml) and allow a confirmation of the diagnosis even during substitution therapy. Clearly elevated ACTH levels (mean 720 pg/ml) are found in 50% of treated CAH patients. In cushing's disease ACl'H concentrations at or above 500 pg/ml of plasma are found. The ACTH-response to a 3 hour metyrapone test was compared between 18 steroid treated patients (29 tests) and 21 tests performed for growth retardation. The tests were analysed based on the following criteria: basal ACTH, < 50-100 pg/ml, increase > 50 pg/ml, maximum > 100 pg/ml. Cortisol basal value 6-13 pg%,-compound-s increase-2 4 pg%. In steroid treated patients a normal Punction was found in 4 tests and signs of incomplete recovery in 1 0 tests. In 6 tests a partial insufficiency was diagnosed. A complete suppression was found in 4 tests. ACTH adrenal function during and after steroid treatment appears to be largely unpredictable. The metyrapone test is valuable in assessing ACTH adrenal function in suspected secondary insufficiences. Plasma ACTH concentrations without stimulation are helpfU for the diagnosis of primary adrenal insufficiency of cushing's disease and for the biochemical control of congenital adrenal hyperplasia. sick pre-adult subjects to characterize the functional state of their gonadotostat. The common methods applied to assess this functional state are not adequate enough to differentiate the quantitative and qualitative patterns of response, and therefore a comparative examination was carried out for the peak increment,net increment, area under the time-response curve till the peak value and the cumulative response, ie, the total area under the time-response curve in each subject. As almost all the parameters were just-normally or lognormally distributed, statistical assessment was based on non-parametric Mann and Whitney test. The cumulative response and median comparison gave more meaningful data, based on the magnitude and shape of the release pattern, for an accurate differential diagnosis.
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(1ntr. by M. Van der Schueren-Lodewiyckx). Department of Pediatrics, Universities of Libge, Leuven and Bruxelles, Belgium. Circadian variations of immunoreactive gonadotropins and gonadotropin-releasing hormone (~n RH) excretion i n timed urinary samples.
Timed urinary collections were obtained i n normal and diabetic children. Urinary hormones excretion was measured i n samples collected from 8 to 12 a.m., 12 to 4 p.m., 4 to 8 p.m. and 8 to 8 a.m. The results were corrected for each period using urine volume and were given i n mIU o r ng per 1 hour. I n prepubertal and pubertal children, the values o f gonadotropins and GnRH were found to be significantly higher (mean 2-3 fold increase) i n urinary samples collected during the morning than i n those obtained during the night. As plasma gonadotropins were previously shown to be increased during the night, the increase of these hormones excretion i n urine might be delayed according to the half life and renal metabolism o f these hormones.
W.BECK (Intr. by P-Stubbe) At start of therapy, average chronological age was 6.8 years and average height age (HA) was 8.6 years. Average advance in bone age (BA) was 2 . years. One patient (aged 5) had already experienced menarche. When on D, menstruation never occured.breast development ceased (3 cases) or regressed (2 cases) but pubarche slightly increased in all cases. In 4 patients treated for 6 months or more mean&HA/ P B A was 1.1., suggesting that B.A. increament was slowed. FSH, LH and E2 levels were not consistently modified. Tolerance of D was good except for transient androgenic manifestations when on high doses (a400 mg/day). Adrenal function was not depressed when evaluated with ACl'H or lysine vasopressine tests. Prolactin levels remained in normal range. These results show that : 1. besides its antigonadotrophic activity, D, a weak androgenic agent, presents direct effects on endometrial tissue. 2. D may be useful in the management of PP in girls with minimal side effects at the daily dose of 200 mg.
"Early normal puberty" (H. Seckel, 1951 ) is no pathological form of sexual development but an extreme variant of the norm. This is a report on 1 1 girls and 2 boys. First pubertal signs, inaccurately remembered in most cases, varied from age 6.25 to 9.0 Menarche occurred with 10.45 -0.95 ys. Statural growth, skeletal and sexual maturation were equally accelerated. Mean predicted adult height (acc. to Tanner) was 176.0 cm for the girls, 175.9 cm for the boys. 3 patients meanwhile ceased to grow; their predicted and definite height was 168.8/168 cm; 175.41 174 cm; 172/171 cm, resp.. Thus, adult height is normal and may be slightly supranormal in early normal puberty, -in contrast to children with precocious puberty. The early sexual maturation appears to be triggered by the forced physical development on the whole, manifested by the advanced bone age. yean difference between chronological and skeletal age was 2.32 -0.7 ys. Acceleration of growth and skeletal maturation seems to be caused by increased secretion of hGH. In 3 girls aged 7.9; 9.75 and 12.3 ys we have determined the nocturnal hGH-secretion. Total secretion was significantly enhanced. The highest peaks measured were 157;70;63 ng/nil. Thus, "early normal puberty" appears to be the exact counterpart to "constit. delay of growth and adolescence" where we have stated a relative lack of total hGHsecretion.
